🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Plasmablastic Lymphoma

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. NCT04915248Phase 218 sites📍 Ancona📍 Aviano📍 Florence Fondazione Italiana Linfomi - ETS · Tests: Daratumumab, Bortezomib, Dexamethasone Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Study on Plasmablastic Lymphoma Patients NCT06781359n/a23 sites📍 Aviano📍 Ascoli Piceno📍 Brescia Fondazione Italiana Linfomi - ETS Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502n/a8 sites📍 La Jolla📍 San Francisco📍 Washington D.C. AIDS Malignancy Consortium · Tests: Biospecimen Collection HEME-25 Open-Label Feasibility Study of Elranatamab Utilized as Consolidation in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV NCT07647432Phase 11 site📍 Chicago University of Illinois Chicago · Tests: Elranatamab (Elra) AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") NCT07649304Phase 11 site📍 Rockville National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Study of SGR-1505 in Mature B-Cell Neoplasms NCT05544019Phase 136 sites📍 Gilbert📍 Newark📍 Pompano Beach Schrödinger, Inc. · Tests: SGR-1505 Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma NCT07332507Phase 120 sites📍 Duarte📍 Irvine📍 Los Angeles National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Positron Emission Tomography, Teclistamab Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas NCT05389423Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: Vincristine, Prednisone, Doxorubicin, Etoposide, Pomalidomide Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma NCT04139304EARLY Phase 19 sites📍 Miami📍 Chicago📍 Baltimore AIDS Malignancy Consortium · Tests: Cyclophosphamide, Daratumumab, Doxorubicin, Doxorubicin Hydrochloride, Etoposide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy